TOCILIZUMAB , CYCLOPHOSPHAMIDE , CD19-CAR_Lenti, FLUDARABINE , LEVETIRACETAM
RF-2021-12375251
Phase 2 small_molecule active
Quick answer
TOCILIZUMAB , CYCLOPHOSPHAMIDE , CD19-CAR_Lenti, FLUDARABINE , LEVETIRACETAM for Refractory Systemic Autoimmune Diseases is a Phase 2 program (small_molecule) at Fondazione Telethon ETS with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Fondazione Telethon ETS
- Indication
- Refractory Systemic Autoimmune Diseases
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active